BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8390070)

  • 1. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy.
    Redvanly RD; Chezmar JL; Strauss RM; Galloway JR; Boyer TD; Bernardino ME
    Radiology; 1993 Jul; 188(1):283-5. PubMed ID: 8390070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.
    Livraghi T; Lazzaroni S; Pellicanò S; Ravasi S; Torzilli G; Vettori C
    AJR Am J Roentgenol; 1993 Nov; 161(5):1065-9. PubMed ID: 8273612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Massive hepatic necrosis secondary to treatment of hepatocellular carcinoma by percutaneous alcoholization].
    Boucher E; Carsin A; Raoul JL; Marchetti C; Joram F; Kerbrat P
    Gastroenterol Clin Biol; 1998 Apr; 22(4):459-61. PubMed ID: 9762276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications following high-dose percutaneous ethanol injection into hepatic tumors.
    Tapani E; Soiva M; Lavonen J; Ristkari S; Vehmas T
    Acta Radiol; 1996 Sep; 37(5):655-9. PubMed ID: 8915270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy.
    Kuang M; Lu MD; Xie XY; Xu HX; Xu ZF; Liu GJ; Yin XY; Huang JF; Lencioni R
    Radiology; 2009 Nov; 253(2):552-61. PubMed ID: 19709992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation.
    Blum M; Mueller C; Peck-Radosavljevic M; Wrba F; Berlakovich G; Mühlbacher F; Steiniger R; Speiser M; Pones M; Hüpfl M; Lammer J; Kettenbach J
    Minim Invasive Ther Allied Technol; 2007; 16(4):230-40. PubMed ID: 17763097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ablative therapies for small hepatocellular carcinoma: radio-frequency or percutaneous ethanol injection?
    Caturelli E
    Radiology; 2000 Jul; 216(1):304-6. PubMed ID: 10887266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complete response (CR) in a case of advanced hepatocellular carcinoma by percutaneous multi-ablation therapy].
    Ishihara K; Beppu T; Ishiko T; Iwagami S; Doi K; Hirota M; Yamashita Y; Ogawa M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1791-4. PubMed ID: 11708036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.